ENDURONYL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Enduronyl, and when can generic versions of Enduronyl launch?
Enduronyl is a drug marketed by Abbott and is included in one NDA.
The generic ingredient in ENDURONYL is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
Summary for ENDURONYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ENDURONYL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ENDURONYL
US Patents and Regulatory Information for ENDURONYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | ENDURONYL | deserpidine; methyclothiazide | TABLET;ORAL | 012775-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbott | ENDURONYL FORTE | deserpidine; methyclothiazide | TABLET;ORAL | 012775-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |